Profile data is unavailable for this security.
About the company
Vilin Bio Med Limited is an India-based company engaged in the business of manufacturing and selling pharmaceutical products. The Company is engaged in the manufacturing of pharmaceutical formulations, such as oral liquids, dry syrups, sachets, external preparations, beta and non-beta lactam tablets and capsules and nutritional food supplements. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotic drugs, central nervous system drugs, alimentary system drugs, genitourinary tract drugs, respiratory system and anti-allergic drugs, anti-diabetic drugs, multi-vitamins, minerals and amino acids supplements, miscellaneous drugs, liquid orals and external preparations. Its cardiovascular drugs include ATORVOSTATIN + Aspirin Capsules, Dapagliflozin 10 milligrams (mg) tablets, Fluvastatin Tablets 40 mg, PRASUGREL 10 mg tablets, and Cilnidipine five mg tablets. Its external preparations include calamine lotion, ciprofloxacin, fluocinolone acetonide and others.
- Revenue in INR (TTM)199.81m
- Net income in INR2.51m
- Incorporated2005
- Employees--
- LocationVilin Bio Med LtdSy no 115, Hanumanji ColonyOpp Sub Register Office, Old BowenpallyHYDERABAD 500009IndiaIND
- Phone+91 9 248000756
- Websitehttps://www.vilinbiomed.co.in/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JFL Life Sciences Ltd | 800.66m | 47.93m | 395.94m | 39.00 | 8.21 | -- | 6.62 | 0.4945 | 1.46 | 1.46 | 24.37 | -- | -- | -- | -- | -- | -- | 5.83 | -- | 10.64 | 22.23 | 18.28 | 6.02 | 5.73 | -- | 5.95 | -- | -- | 76.25 | 22.15 | 25.72 | 63.09 | -32.30 | -- |
| Jupiter Bioscience Ltd | -100.00bn | -100.00bn | 399.59m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.42 | -- | 5.61 | -- | 61.37 | -- | 17.32 | -- | -- | -- | 10.48 | 42.43 | 29.30 | 20.92 | 22.82 | 55.40 | -16.74 |
| Lasa Supergenerics Ltd | 952.91m | -361.68m | 447.40m | 66.00 | -- | 0.7941 | -- | 0.4695 | -7.57 | -7.57 | 19.58 | 11.25 | 0.8705 | 6.06 | 36.08 | 14,437,960.00 | -33.04 | -6.42 | -46.76 | -8.54 | 22.28 | 28.58 | -37.96 | -8.05 | 0.5203 | -14.70 | 0.1152 | -- | 36.53 | -3.16 | 32.09 | -- | -- | -- |
| Vilin Bio Med Ltd | 199.81m | 2.51m | 473.60m | -- | 188.20 | 2.04 | 133.30 | 2.37 | 0.1804 | 0.1804 | 14.34 | 16.64 | 0.6845 | 3.65 | 3.25 | -- | 0.8592 | 1.81 | 1.08 | 2.70 | 6.60 | 21.72 | 1.26 | 2.71 | 4.16 | 1.19 | 0.0193 | -- | -6.30 | -2.51 | 37.62 | 6.62 | 130.50 | -- |
| Mangalam Drugs and Organics Ltd | 2.38bn | -309.21m | 517.43m | 414.00 | -- | -- | -- | 0.217 | -19.53 | -19.53 | 150.57 | -- | -- | -- | -- | 5,758,911.00 | -- | 2.90 | -- | 5.34 | 39.15 | 29.02 | -12.97 | 2.46 | -- | -0.9827 | -- | -- | -13.66 | 2.42 | 174.27 | -4.02 | 23.85 | -- |
| Biofil Chemicals and Pharmaceuticals Ltd | 425.20m | 28.59m | 584.39m | 26.00 | 20.49 | 2.74 | 18.42 | 1.37 | 1.75 | 1.75 | 25.87 | 13.09 | 0.8731 | 7.84 | 1.28 | 16,353,690.00 | 5.87 | 2.13 | 14.16 | 4.33 | 5.22 | 8.63 | 6.72 | 2.33 | 1.33 | 8.28 | 0.0009 | -- | -16.57 | 2.38 | -21.36 | -14.31 | -13.50 | -- |
| Vineet Laboratories Ltd | 570.37m | -166.97m | 590.98m | -- | -- | 2.36 | -- | 1.04 | -15.30 | -15.30 | 52.08 | 13.02 | 0.5785 | 1.01 | 4.23 | -- | -16.94 | -1.82 | -54.66 | -5.75 | 4.86 | 19.76 | -29.27 | -1.09 | 0.1186 | -3.06 | 0.7505 | -- | -50.20 | -- | -2,065.83 | -- | -- | -- |
